[20220217]IF12013_美国政府在国内和全球2019冠状病毒疾病疫苗供应和分发中的作用：常见问题解答.pdf

https:/crsreports.congress.gov Updated February 17, 2022The U.S. Governments Role in Domestic and Global COVID-19 Vaccine Supply and Distribution: Frequently Asked QuestionsThis In Focus answers frequently asked questions regarding U.S. funding and support for domestic and global vaccine supply and distribution, including Coronavirus Disease 2019 (COVID-19) vaccines. Unless otherwise stated, information is current as of February 17, 2022. Domestic Vaccine Development, Purchasing, and Distribution Which federal agencies funded the development and manufacturing of COVID-19 vaccines? Numerous federal entities supported COVID-19 vaccine development and manufacturing, including the National Institutes of Health (NIH), the Biomedical Advanced Research and Development Authority (BARDA), the Department of Defense (DOD), and others, both within and separately from the Operation Warp Speed (OWS) initiative. See CRS In Focus IF11951, Domestic Funding for COVID-19 Vaccines: An Overview for more information. This section focuses on domestic BARDA efforts. What agreements did the U.S. government enter into with vaccine manufacturers for COVID-19 vaccine development, manufacturing, and purchase?